VGL101

· Vigil Neuroscience, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VGL101, covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia [Phase 2]

See pricing